Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Joost P.J.J Hegmans"'
Autor:
Lisanne Noordam, Margaretha E.H. Kaijen, Koen Bezemer, Robin Cornelissen, Lex A.P.W.M. Maat, Henk C. Hoogsteden, Joachim G.J.V. Aerts, Rudi W. Hendriks, Joost P.J.J Hegmans, Heleen Vroman
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
Rationale: Regulatory T cells (Treg) play a pivotal role in the immunosuppressive tumor micro-environment in cancer, including mesothelioma. Recently, the combination of autologous tumor lysate-pulsed dendritic cells (DC) and metronomic cyclophospham
Externí odkaz:
https://doaj.org/article/5511702cf6784ad3925ba874ceb4f0f3
Autor:
Henk C. Hoogsteden, Joost P.J.J. Hegmans, Rudi W. Hendriks, Arnold G. Vulto, Bronno van der Holt, Eric Braakman, Cynthia Waasdorp, Ferry A.L.M. Eskens, André Kunert, Niken M. Mahaweni, Cor H. van der Leest, Koen Bezemer, Margaretha E.H. Kaijen-Lambers, Robin Cornelissen, Pauline L. de Goeje, Joachim G.J.V. Aerts
Purpose: Mesothelioma has been regarded as a nonimmunogenic tumor, which is also shown by the low response rates to treatments targeting the PD-1/PD-L1 axis. Previously, we demonstrated that autologous tumor lysate–pulsed dendritic cell (DC) immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47c01604ce053715c2dca9b66ef0a9ab
https://doi.org/10.1158/1078-0432.c.6525983.v1
https://doi.org/10.1158/1078-0432.c.6525983.v1
Autor:
Henk C. Hoogsteden, Joost P.J.J. Hegmans, Rudi W. Hendriks, Arnold G. Vulto, Bronno van der Holt, Eric Braakman, Cynthia Waasdorp, Ferry A.L.M. Eskens, André Kunert, Niken M. Mahaweni, Cor H. van der Leest, Koen Bezemer, Margaretha E.H. Kaijen-Lambers, Robin Cornelissen, Pauline L. de Goeje, Joachim G.J.V. Aerts
Supplementary Material and Methods: Preparation of allogeneic tumor lysate Figure S1: CD8 T-cells from DC immunotherapy treated mice show tumor cell killing capacity Figure S2: Progression free survival of patients in the first-in-human clinical stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f97b6c8e3225f046d755e41fbb18e34
https://doi.org/10.1158/1078-0432.22465283.v1
https://doi.org/10.1158/1078-0432.22465283.v1
Autor:
Niken M. Mahaweni, Margaretha E.H. Kaijen-Lambers, Jacqueline Dekkers, Joachim G.J.V. Aerts, Joost P.J.J. Hegmans
Publikováno v:
Journal of Extracellular Vesicles, Vol 2, Iss 0, Pp 1-6 (2013)
Background: In 2001, it was postulated that tumour-derived exosomes could be a potent source of tumour-associated antigens (TAA). Since then, much knowledge is gained on their role in tumorigenesis but only very recently tumour-derived exosomes were
Externí odkaz:
https://doaj.org/article/62dc7e2ad46948b7b9950631980dc4d1
Autor:
Bronno van der Holt, Pauline L. de Goeje, Cynthia Waasdorp, Eric Braakman, Joachim G.J.V. Aerts, Andre Kunert, Rudi W. Hendriks, Henk C. Hoogsteden, Margaretha E.H. Kaijen-Lambers, Joost P.J.J. Hegmans, Robin Cornelissen, Koen Bezemer, Ferry A.L.M. Eskens, Cor van der Leest, Niken M. Mahaweni, Arnold G. Vulto
Publikováno v:
Clinical Cancer Research, 24(4), 766-776. American Association for Cancer Research Inc.
Purpose: Mesothelioma has been regarded as a nonimmunogenic tumor, which is also shown by the low response rates to treatments targeting the PD-1/PD-L1 axis. Previously, we demonstrated that autologous tumor lysate–pulsed dendritic cell (DC) immuno
Autor:
Koen Bezemer, Sjaak Philipsen, Jun Hou, L. L. de Vogel, Bruno H. Stricker, Sabine Visser, Joachim G.J.V. Aerts, Joost P.J.J. Hegmans
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, 19:440. BioMed Central Ltd.
BMC Cancer
BMC Cancer, 19:440. BioMed Central Ltd.
BMC Cancer
Background Palliative pemetrexed-based chemotherapy remains a standard of care treatment for the majority of patients with advanced non-squamous non-small-cell lung cancer (NSCLC). Currently, no predictive markers for pemetrexed treatment are availab
Autor:
Henk C. Hoogsteden, Floris Dammeijer, Lidia R. Arends, Joost P.J.J. Hegmans, Lysanne A. Lievense, G.D. Marijn Veerman, Joachim G.J.V. Aerts
Publikováno v:
Journal of Clinical Oncology, 34(26), 3204-3212. American Society of Clinical Oncology
Purpose Programmed cell death protein-1- checkpoint blockers have recently been approved as second-line treatment for advanced non–small-cell lung cancer (NSCLC). Unfortunately, only a subgroup of patients responds and shows long-term survival to t
Autor:
Henk C. Hoogsteden, Lisanne Noordam, Rudi W. Hendriks, Heleen Vroman, Koen Bezemer, Lex P.W.M. Maat, Joachim G.J.V. Aerts, Robin Cornelissen, Joost P.J.J. Hegmans, Margaretha E H Kaijen
Publikováno v:
OncoImmunology, 7(12):e1474318. Landes Bioscience
Oncoimmunology
OncoImmunology, Vol 7, Iss 12 (2018)
Oncoimmunology
OncoImmunology, Vol 7, Iss 12 (2018)
Rationale: Regulatory T cells (Treg) play a pivotal role in the immunosuppressive tumor micro-environment in cancer, including mesothelioma. Recently, the combination of autologous tumor lysate-pulsed dendritic cells (DC) and metronomic cyclophospham
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a67cda43e7414dc8e754c6f77bcca4d
https://pure.eur.nl/en/publications/7d18c987-5296-457f-bcec-c56036fc8fbe
https://pure.eur.nl/en/publications/7d18c987-5296-457f-bcec-c56036fc8fbe
Autor:
Suresh Senan, Cynthia Waasdorp, Alexander P.W.M. Maat, Margaretha E.H. Kaijen-Lambers, Rudi W. Hendriks, Koen Bezemer, Koen J. Hartemink, Joachim G.J.V. Aerts, Joost J. Nuyttens, Mark de Mol, Egbert F. Smit, Merel T B Schram, Pauline L. de Goeje, Joost P.J.J. Hegmans
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 196(9), 1224-1227. American Thoracic Society
De Goeje, P L, Smit, E F, Waasdorp, C, Schram, M T B, Kaijen-Lambers, M E H, Bezemer, K, De Mol, M, Hartemink, K J, Nuyttens, J J M E, Maat, A P W M, Hegmans, J P J J, Hendriks, R W, Senan, S & Aerts, J G J V 2017, ' Stereotactic ablative radiotherapy induces peripheral t-cell activation in patients with early-stage lung cancer ', American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 9, pp. 1224-1227 . https://doi.org/10.1164/rccm.201610-2178LE
De Goeje, P L, Smit, E F, Waasdorp, C, Schram, M T B, Kaijen-Lambers, M E H, Bezemer, K, De Mol, M, Hartemink, K J, Nuyttens, J J M E, Maat, A P W M, Hegmans, J P J J, Hendriks, R W, Senan, S & Aerts, J G J V 2017, ' Stereotactic ablative radiotherapy induces peripheral t-cell activation in patients with early-stage lung cancer ', American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 9, pp. 1224-1227 . https://doi.org/10.1164/rccm.201610-2178LE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d32029c5ce63f69c99a00a907275fe08
https://research.vumc.nl/en/publications/bd84b4eb-0042-48f8-a7e8-7901c0a41b8e
https://research.vumc.nl/en/publications/bd84b4eb-0042-48f8-a7e8-7901c0a41b8e
Publikováno v:
Cancer Genetics and Genomics for Personalized Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8775da43b2c1523bb31a4354b7ccfac
https://doi.org/10.1201/9781315364766-8
https://doi.org/10.1201/9781315364766-8